A carregar...

Pharmacodynamic Biomarkers for Emerging LRRK2 Therapeutics

Genetic studies have identified variants in the LRRK2 gene as important components of Parkinson’s disease (PD) pathobiology. Biochemical and emergent biomarker studies have coalesced around LRRK2 hyperactivation in disease. Therapeutics that diminish LRRK2 activity, either with small molecule kinase...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurosci
Main Authors: Kelly, Kaela, West, Andrew B.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7438883/
https://ncbi.nlm.nih.gov/pubmed/32903744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2020.00807
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!